Malignant Blood Vessel Neoplasm — Trials

Malignant Blood Vessel Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

191 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 36
Recruiting: 22
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 101–110 of 110 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002212	A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma	completed	Phase 2	27	Ligand PharmaceuticalsINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00002226	Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma	completed	N/A	30	SUGENINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00002259